Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - March 2011

The National Institute of Health and Clinical Excellence has published new guidance for the month of March 2011. This month there are two public health guidelines, one clinical guideline, and one technology appraisal that impact upon primary care.

The public health guidelines both relate to increasing HIV testing uptake in black Africans and men who have sex with men.

The clinical guideline discusses the diagnosis and treatment of active and latent tuberculosis in adults and children and strategies to prevent the spread of tuberculosis.

The technology appraisal is an update to a previous appraisal for the drug treatment of Alzheimer's disease. The review covers donepezil, galantamine, rivastigmine and memantine. Key changes in the update are that donepezil, galantamine and rivastigmine are now recommended in mild as well as moderate disease and memantine is now an option in moderate disease.

Action: Clinicians should be aware of these recommendations and implement any necessary changes to practice.

Share 'NICE Guidance - March 2011' on Email Share 'NICE Guidance - March 2011' on Delicious Share 'NICE Guidance - March 2011' on Digg Share 'NICE Guidance - March 2011' on Facebook Share 'NICE Guidance - March 2011' on Google+ Share 'NICE Guidance - March 2011' on reddit Share 'NICE Guidance - March 2011' on StumbleUpon Share 'NICE Guidance - March 2011' on Twitter

atomic-wealth

No Comments to “NICE Guidance - March 2011”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,308 spam comments.

atomic-wealth
fond-illness
summer